Long-term efficacy and safety of intravenous (IV) Tulisokibart in patients with crohn’s disease (CD): Results from the open-label extension period of the phase 2 APOLLO-CD study - Sossdorf, M; Siegel, C A; Leong, R W; Anderson, J K; Yen, M; Dong, B; Sands, B E; Danese, S; Feagan, B G (Zeitschrift für Gastroenterologie, 2025)